Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition
Open Access
- 1 December 2000
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 53 (12) , 917-923
- https://doi.org/10.1136/jcp.53.12.917
Abstract
Aims—To determine the effects of fetal macrosomia related to maternal type 1 diabetes on the lipid transport system. Methods—Serum lipoprotein concentrations and composition and lecithin:cholesterol acyltransferase (LCAT) activity were investigated in macrosomic newborns (mean birth weight, 4650 g; SEM, 90) and their mothers with poorly controlled type 1 diabetes, in appropriate for gestational age newborns (mean birth weight, 3616 g; SEM, 68) and their mothers with well controlled type 1 diabetes, and macrosomic (mean birth weight, 4555 g; SEM, 86) or appropriate for gestational age (mean birth weight, 3290 g; SEM, 45) newborns and their healthy mothers. Results—In mothers with well controlled type 1 diabetes, serum lipids, apolipoproteins, and lipoproteins were comparable with those of healthy mothers. Similarly, in their infants, these parameters did not differ from those of appropriate for gestational age newborns. Serum triglyceride, very low density lipoprotein (VLDL), apolipoprotein B100 (apo B100), and high density lipoprotein (HDL) triglyceride concentrations were higher, whereas serum apo A-I and HDL3 concentrations were lower in mothers with diabetes and poor glycaemic control than in healthy mothers. Their macrosomic newborns had higher concentrations in all serum lipids and lipoproteins, with high apo A-I and apo B100 values compared with appropriate for gestational age newborns. In macrosomic infants of healthy mothers, there were no significant differences in lipoprotein profiles compared with those of appropriate for gestational age infants. LCAT activity was similar in both groups of mothers and newborns. Conclusion—Poorly controlled maternal type 1 diabetes and fetal macrosomia were associated with lipoprotein abnormalities. Macrosomic lipoprotein profiles related to poor metabolic control of type 1 diabetes appear to have implications for later metabolic diseases.Keywords
This publication has 45 references indexed in Scilit:
- Substrate delivery as a determinant of hepatic apoB secretion.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Lipoprotein Physiology in Nondiabetic and Diabetic States: Relationship to AtherogenesisDiabetes Care, 1991
- Lecithin-cholesterol acyltransferase in newborn infants: Low activity level in preterm infantsThe Journal of Pediatrics, 1988
- Simple predictive model for flavor production in hadronizationPhysical Review Letters, 1987
- Isolation and properties of porcine lecithin: cholesterol acyltransferaseEuropean Journal of Biochemistry, 1986
- Application of SDS gradient polyacrylamide slab gel electrophoresis to analysis of apolipoprotein mass and radioactivity of rat lipoproteinsAtherosclerosis, 1984
- Excessive Obesity in Offspring of Pima Indian Women with Diabetes during PregnancyNew England Journal of Medicine, 1983
- Cord blood serum in newborns of diabetic mothersJournal of Chronic Diseases, 1983
- Somatic growth of children of diabetic mothers with reference to birth sizeThe Journal of Pediatrics, 1980
- Some properties of a cholesterol esterifying enzyme in human plasmaBiochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects, 1964